Spanu Pennestri, Teresa
 Distribuzione geografica
Continente #
EU - Europa 6.741
NA - Nord America 5.468
AS - Asia 2.038
AF - Africa 48
SA - Sud America 44
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 9
Totale 14.378
Nazione #
US - Stati Uniti d'America 5.432
DE - Germania 3.113
CN - Cina 1.492
SE - Svezia 826
IT - Italia 648
UA - Ucraina 476
PL - Polonia 415
FR - Francia 311
GB - Regno Unito 267
IE - Irlanda 246
SG - Singapore 181
FI - Finlandia 136
IN - India 121
RU - Federazione Russa 115
TR - Turchia 110
BE - Belgio 43
AT - Austria 40
CA - Canada 28
AU - Australia 26
IR - Iran 24
BR - Brasile 21
HK - Hong Kong 19
JP - Giappone 18
NL - Olanda 17
CH - Svizzera 16
MA - Marocco 16
ES - Italia 15
PH - Filippine 13
CZ - Repubblica Ceca 11
MT - Malta 9
EG - Egitto 8
VA - Santa Sede (Città del Vaticano) 8
CI - Costa d'Avorio 7
EU - Europa 7
ID - Indonesia 7
IQ - Iraq 7
KR - Corea 7
VN - Vietnam 7
PE - Perù 6
PK - Pakistan 6
SD - Sudan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
MY - Malesia 5
AR - Argentina 4
CO - Colombia 4
GR - Grecia 4
NZ - Nuova Zelanda 4
EC - Ecuador 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
MX - Messico 3
NG - Nigeria 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BG - Bulgaria 2
CU - Cuba 2
GT - Guatemala 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
YE - Yemen 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
KZ - Kazakistan 1
ME - Montenegro 1
NO - Norvegia 1
SC - Seychelles 1
SN - Senegal 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 14.378
Città #
Chandler 1.083
Hangzhou 604
Ashburn 429
Warsaw 361
Jacksonville 350
Ann Arbor 267
San Mateo 253
Dublin 240
Nürnberg 226
Woodbridge 216
Nanjing 213
Wilmington 200
Dearborn 176
Fairfield 175
Beijing 148
New York 140
Seattle 138
Houston 130
Boston 102
Singapore 99
Izmir 97
Milan 87
Moscow 84
Lawrence 80
Cattolica 79
Marseille 76
Rome 76
Nanchang 72
Chicago 65
Redwood City 61
Princeton 57
Cambridge 53
Kraków 51
Munich 50
Kunming 48
Bremen 42
Shenyang 42
Brussels 39
Los Angeles 39
Helsinki 38
Mountain View 37
Vienna 37
Boardman 36
Guangzhou 35
Tianjin 32
Hebei 29
Jiaxing 27
Norwalk 27
Zhengzhou 27
Redmond 24
Changsha 23
Falls Church 22
Fremont 22
Lancaster 21
Leawood 18
University Park 18
Simi Valley 17
Augusta 16
Hong Kong 16
Hefei 15
London 15
Pune 15
Jinan 14
Shanghai 14
Buffalo 12
Costa Mesa 12
Ningbo 12
Kish 11
San Diego 11
Phoenix 10
Sydney 10
Washington 10
Zurich 10
Auburn Hills 9
Brno 9
Fuzhou 9
Lanzhou 9
Andover 8
Melbourne 8
Mumbai 8
Ottawa 8
Paris 8
Philadelphia 8
São Paulo 8
Turin 8
Verona 8
Abidjan 7
Cairo 7
Changchun 7
Dalmine 7
Dong Ket 7
Indiana 7
Nashville 7
Toronto 7
Baghdad 6
Detroit 6
Edinburgh 6
Florence 6
Gunzenhausen 6
Kocaeli 6
Totale 7.641
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 379
Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit. 361
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 308
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 307
Factors associated with mortality in bacteremic patients with haematologic malignancies 295
Factors associated with mortality in bacteremic patients with hematologic malignancies. 295
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 274
In vitro Evaluation of BACT/ALERT® VIRTUO®, BACT/ALERT 3D®, and BACTEC™ FX Automated Blood Culture Systems for Detection of Microbial Pathogens Using Simulated Human Blood Samples 240
Diabetic foot infections: a comprehensive overview 239
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 223
A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry 216
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 211
Empyema caused by Prevotella bivia complicating an unusual case of spontaneous chylothorax. 208
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 188
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 188
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 188
Application of MALDI-TOF mass spectrometry in clinical diagnostic microbiology 175
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 168
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 159
Factors associated with mortality in bacteremic patients with hematologic malignancies. 159
Development of a Multiplex PCR Platform for the Rapid Detection of Bacteria, Antibiotic Resistance, and Candida in Human Blood Samples 159
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 156
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 147
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 147
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 147
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli 144
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 143
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 138
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 135
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 134
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 130
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 130
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 129
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 128
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 120
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 119
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 118
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 116
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 116
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 116
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 113
Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno (TM) and VITEK (R) 2 systems with the broth microdilution method 111
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 110
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 109
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 109
Catheter-related bacteremia by Cupriavidus metallidurans 107
Pertussis in infants less than 6 months of age and household contacts, Italy April 2014 106
Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli 104
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man 104
Molecular identification of Leuconostoc mesenteroides as a cause of brain abscess in an immunocompromised patient 104
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 101
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 100
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 99
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 96
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 96
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 96
Molecular identification of Leuconostoc mesenteroides as a cause of brain abscess in an immunocompromised patient 95
Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? 95
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man. 94
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 93
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series 93
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 89
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study--authors' response 89
Ventriculitis due to Staphylococcus lugdunensis: two case reports 88
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 87
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 87
Direct MALDI-TOF MS Testing from Positive Blood Cultures for Rapid Identification of Bloodstream Infection-Causing Anaerobic Bacteria 87
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 84
Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis 84
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy 83
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. 83
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 82
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 81
Compliance of clinical microbiology laboratories with recommendations for the diagnosis of bloodstream infections 81
Clinical impact of pulmonary sampling site in the diagnosis of ventilator-associated pneumonia: A prospective study using bronchoscopic bronchoalveolar lavage 80
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification of bloodstream infection staphylococcal isolates 79
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 79
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 78
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 77
Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories 75
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 75
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 75
First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae 73
Lice, rodents, and many hopes: a rare disease in a young refugee 73
Implementation of the eazyplex(®) CSF direct panel assay for rapid laboratory diagnosis of bacterial meningitis: 32-month experience at a tertiary care university hospital 73
A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections 72
Predictors of mortality among adult, old and the oldest old patients with bloodstream infections: An age comparison 72
HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era 70
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 70
Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 70
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 70
Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles 69
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 69
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) 69
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 69
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 68
Reply to Seligman 68
Rapidly Fatal Hemorrhagic Pneumonia and Group A Streptococcus Serotype M1 68
Efficient Recovery of Candida auris and Five Other Medically Important Candida Species from Blood Cultures Containing Clinically Relevant Concentrations of Antifungal Agents 67
Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting 67
Totale 12.568
Categoria #
all - tutte 46.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.221 0 207 182 155 243 281 256 117 201 179 229 171
2020/20211.473 110 150 18 127 187 140 206 56 183 52 204 40
2021/20221.365 112 113 44 81 67 83 46 239 59 83 211 227
2022/20233.069 371 418 206 430 204 341 149 278 387 93 124 68
2023/20241.364 86 353 39 84 64 197 86 77 15 60 131 172
2024/202589 73 16 0 0 0 0 0 0 0 0 0 0
Totale 14.531